A Device Improves Signs and Symptoms of TMD
| Autor: | Cattaneo, Ruggero, Pietropaoli, Davide, Cooper, Barry C., Capparè, Dino, Ortu, Eleonora, Monaco, Annalisa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Orofacial pain Adolescent Article Subject medicine.medical_treatment Female Humans Middle Aged Temporomandibular Joint Disorders Transcutaneous Electric Nerve Stimulation Orthodontic Appliances Signs and symptoms Orthotics law.invention Randomized controlled trial law medicine In patient Practical implications lcsh:R5-920 Rehabilitation business.industry Temporomandibular joint stomatognathic diseases Anesthesiology and Pain Medicine medicine.anatomical_structure Neurology Physical therapy medicine.symptom business lcsh:Medicine (General) Research Article |
| Zdroj: | Pain Research and Management, Vol 2019 (2019) Pain Research & Management |
| ISSN: | 1203-6765 |
| DOI: | 10.1155/2019/5646143 |
| Popis: | Background. Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain.Methods. 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study (n = 25) and control groups (n = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation.Results. T1 study group compared to controls showed a significant reduction in total (p<0.0001) and mean (p<0.0001) sEMG values, as well as a significant increase in both maximum vertical mouth opening (p=0.003) and maximum velocity in mouth opening (p=0.003) and closing (p<0.0001). Interestingly, a significant reduction in pain measured by VAS (p<0.0001) was reported.Conclusions. After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values.Practical Implications. ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text